166. Management of Multiple Sclerosis from Patients', Physicians', and Patient Group's Perspectives in Saudi Arabia

Salman Aljarallah,Nuha Alkhawajah,Fatima Zhrani,Hazem Wahba

DOI: https://doi.org/10.1016/j.msard.2024.106127

IF: 4.808

2024-12-15

Multiple Sclerosis and Related Disorders

Abstract:Background/Objective(s) Multiple sclerosis (MS) is a chronic, neurodegenerative disease affecting approximately 2.8 million people worldwide. Its prevalence has grown significantly, with countries like Saudi Arabia reporting a rate of around 40.4 per 100,000 individuals. The most common subtype, Relapsing-remitting MS (RRMS), affects 65%-75% of patients. Though no cure exists, disease-modifying treatments (DMTs) can prevent relapses and reduce long-term disability. Recent developments have introduced high-efficacy DMTs with differing mechanisms of action. However, these may be underutilized despite their effectiveness. Additionally, the importance of patient Quality of Life (QoL) is increasingly recognized in treatment selection, though several obstacles persist. Material(s) and Method(s) A qualitative research approach was used, involving focus group discussions among 8 patients, 2 neurologists, and the head of 2 patient societies (Arfa and Wasm). These patients suffered from RRMS and had varied educational backgrounds. The discussions were conducted in Arabic by representatives from IQVIA, lasting 60 minutes for specialists and the head of the patient societies, and 2 hours for patients. The interviews and the patients advisory boards' reports were transcribed and analyzed using thematic analysis. Result(s) The causes of patients' symptoms were initially unclear to them until they consulted physicians when these symptoms worsened. The delay in MS diagnosis was attributed to a shortage of multidisciplinary physicians in smaller cities, leading to a deterioration of the condition. After diagnosis, a degree of uncertainty and denial of the neurologist's advice was observed. Some patients felt that due to limited clinic time, their concerns were not being adequately addressed and turned to social media for accessibility and convenience. They wanted family support, less frequent hospital visits due to stressful jobs, and to save time and money. They also expressed a preference for monthly high-efficacy, self-administered subcutaneous injections over hospital treatments. Conclusion(s) The study highlighted several unmet patient needs on the RRMS journey and emphasized the need for high-efficacy treatment options for better patient outcomes. It also indicated that patient experiences and perspectives could provide valuable insight into improving care and management strategies for MS.

clinical neurology